Heart failure is epidemic in the United States with a prevalence of over 5 million. The diagnosis carries a mortality risk of 50 % at 5 years rivaling many diagnoses of cancer. Heart transplantation, long the «gold standard» treatment for end stage heart failure

Objective. To assess the potential benefit of digital health interventions (DHIs) on cardiovascular disease (CVD) outcomes (CVD events, all-cause mortality, hospitalizations) and risk factors compared with non-DHIs. Patients and Methods. We conducted a systematic search of

In 1988 T. G. Pickering et al. described the development of pulmonary oedema in patients with bilateral renal artery stenosis. The authors reported a series of 11 hypertensive patients with bilateral RAS, who presented with a history of multiple episodes of acute heart

Atrial septal defect (ASD) is a frequent congenital heart disease, which occurs in the form of secondary or birth defect and defect of venous or coronary sinus. Pathophysiology: ASD often occur only in adulthood with arrhythmias, paradoxical embolism, cerebral abscesses,

* Статья написана специально для журнала "Кардиология: новости, мнения, обучение".

Physical inactivity is major risk factors for the development of many age-related diseases, which include and diseases of the cardiovascular system. Telomeres many scientists are recognised as a biological marker of aging. Low levels of physical activity are associated with

To compare the efficacy and safety of allapinine, ethacyzin and amiodarone in preventing paroxysms of atrial fibrillation and/or flutter resistant to class IA antiarrhythmic drugs a randomized open parallel study was conducted followed by crossover serial testing in

Anticoagulants are widely used in modern medicine for the prevention of thrombotic and thromboembolic complications. The first drug of this group was warfarin per os . Currently there are a lot of drugs of the new generation, but in many cases, warfarin is still the drug of

Article presents the main results of SERAPHIN study [effect of new endothelin receptor antagonist macitentan on patients with pulmonary arterial hypertension (PAH)]. The obtained findings confirm high efficiency of macitentan and good tolerance to the drug for patients with

Chronic thromboembolic pulmonary hypertension (CTEPH) is a special form of pulmonary hypertension, both in terms of etiology, and in terms of treatment. This review presents modern approaches to the management of patients with CTEPH. Today riociguat can be regarded as a

The key issue of the treatment of patients with myocardial infarction is the definition of tactics and timing of myocardial revascularization. Remains an important question of myocardial revascularization in the acute and subacute phase of myocardial infarction if

Based on published data, the diagnosis of pheochromocytoma is established posthumously in 30–60 % of cases, with the most frequent localization in the adrenals. There are rare recurrences of tumors after the surgical treatment and do not exceed 10 %. As a rule,